CHEMOMAB LTD has a total of 16 patent applications. It increased the IP activity by 150.0%. Its first patent ever was published in 2015. It filed its patents most often in Israel, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are AVIPEP PTY LTD, LABRYS BIOLOGICS INC and IMMUGENICS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | Israel | 3 | |
#2 | United States | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Brazil | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Mor Adi | 12 |
#2 | Adi Mor | 1 |
Publication | Filing date | Title |
---|---|---|
WO2017183028A1 | Eotaxin-2 inhibitors in the treatment of fibromyalgia | |
IL251024D0 | Anti eotaxin 2 antibodies for use in the treatment of hepatic diseases | |
CN106103479A | Identify anti-chemotactic factor for eosinophils 2 antibody of other CCR3 binding chemotactic factors |